Developing an Affordable Newborn Sepsis Calculator for Resource-Limited Settings

Recent Trends

In low- and middle-income countries, neonatal mortality remains high partly due to delayed or inaccurate diagnosis of sepsis. Recent efforts have focused on adapting clinical decision support tools—originally designed for well-equipped hospitals—to settings with minimal laboratory capacity. Several pilot projects are now testing simplified sepsis calculators that rely on a small set of vital signs, maternal history, and basic clinical observations instead of blood cultures or advanced biomarkers.

Background

Newborn sepsis is a leading cause of death in the first 28 days of life. In resource-limited settings, diagnosis is often based on the World Health Organization’s (WHO) criteria for possible serious bacterial infection, which can lead to overtreatment with antibiotics or missed cases. Existing high-income country calculators incorporate variables such as gestational age, temperature, and lab results. However, these models may not be directly transferable due to differences in disease prevalence, antibiotic resistance patterns, and access to diagnostics. The goal of an affordable new calculator is to retain high sensitivity while reducing dependence on costly or unavailable tests.

User Concerns

• Accuracy trade-offs: Clinicians worry that a simplified tool may miss subtle signs, especially in preterm or low-birth-weight infants where sepsis presentation is atypical.
• Training and trust: Health workers accustomed to syndrome-based algorithms may be hesitant to rely on a numeric risk score without clear decision thresholds.
• Data quality: Calculator performance depends on consistent measurement of vital signs (e.g., respiratory rate, temperature) and reliable maternal history—both of which can be inconsistent in busy clinics.
• Antibiotic stewardship: While reducing unnecessary antibiotics is a goal, any tool that lowers treatment rates must be proven safe in settings where follow-up is limited.

Likely Impact

If validated in diverse primary-care and district-hospital settings, an affordable sepsis calculator could:

• Reduce unnecessary antibiotic exposure, helping curb antimicrobial resistance.
• Improve early detection in facilities without blood culture capability, reducing referral delays.
• Standardise care across providers with varying experience levels, potentially lowering neonatal mortality in the long run.
• Provide a low-cost digital or paper-based tool that integrates with existing maternal and child health programmes.

What to Watch Next

• Prospective validation studies in at least two or three low-resource country contexts, comparing the calculator against a composite reference standard that includes clinical follow-up.
• User experience research on how nurses and midwives interact with the tool under real-world workflow constraints.
• Efforts to link the calculator to simple point-of-care tests (e.g., C-reactive protein or procalcitonin alternatives) and see if combined models improve accuracy.
• Cost-effectiveness analyses that weigh the tool’s development and training costs against savings from reduced antibiotic use, hospital stays, and adverse events.